Mark Dipaolo
Chairman en INNOVIVA, INC. .
Fortuna: 2 M $ al 31/03/2024
Perfil
Mark A.
Dipaolo is currently the Chairman at Innoviva, Inc., an Independent Director at Amarin Corp.
Plc, and a Senior Managing Director at Sarissa Capital Acquisition Corp.
Previously, he served as an Independent Director at Novelion Therapeutics, Inc. and worked as an Attorney at Willkie Farr & Gallagher LLP.
Mr. Dipaolo obtained his undergraduate degree from Fordham University and his graduate degree from Georgetown University Law Center.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
INNOVIVA, INC.
0.17% | 22/05/2023 | 104 706 ( 0.17% ) | 2 M $ | 31/03/2024 |
AMARIN CORPORATION
-.--% | 18/04/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Mark Dipaolo
| Empresas | Cargo | Inicio |
|---|---|---|
| INNOVIVA, INC. | Chairman | 22/05/2023 |
| SARISSA CAPITAL ACQUISITION CORP. | Corporate Officer/Principal | 20/10/2020 |
| AMARIN CORPORATION PLC | Director/Board Member | 28/02/2023 |
Antiguos cargos conocidos de Mark Dipaolo.
| Empresas | Cargo | Fin |
|---|---|---|
| NOVELION THERAPEUTICS INC. | Director/Board Member | 13/09/2018 |
Willkie Farr & Gallagher LLP
 Willkie Farr & Gallagher LLP Miscellaneous Commercial ServicesCommercial Services Willkie Farr & Gallagher LLP engages in the provision of legal services. It specializes in antitrust and competition, asset management, business reorganization and restructuring, communications and media, corporate and financial services, cybersecurity and privacy, energy, and executive compensation and employee benefits practice areas. The company was founded in 1888 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/09/2018 |
Formación de Mark Dipaolo.
| Fordham University | Undergraduate Degree |
| Georgetown University Law Center | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| AMARIN CORPORATION PLC | Health Technology |
| INNOVIVA, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Willkie Farr & Gallagher LLP
Willkie Farr & Gallagher LLP Miscellaneous Commercial ServicesCommercial Services Willkie Farr & Gallagher LLP engages in the provision of legal services. It specializes in antitrust and competition, asset management, business reorganization and restructuring, communications and media, corporate and financial services, cybersecurity and privacy, energy, and executive compensation and employee benefits practice areas. The company was founded in 1888 and is headquartered in New York, NY. | Commercial Services |
Novelion Therapeutics, Inc.
 Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelion Therapeutics, Inc. engaged in the development and commercialization of pharmaceuitical products. It focused in providing new standards of care for individuals living with rare diseases. The company was founded on February 3, 1981 and was headquartered in Vancouver, Canada. | Health Technology |
Sarissa Capital Acquisition Corp.
 Sarissa Capital Acquisition Corp. Financial ConglomeratesFinance Sarissa Capital Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, and reorganization or similar business combination with one or more businesses. The company was founded on August 12, 2020 and is headquartered in Greenwich, CT. | Finance |
- Bolsa de valores
- Insiders
- Mark Dipaolo
